Inkeun Park
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety Evaluation of Tarlatamab in Advanced Extrapulmonary Neuroendocrine Carcinoma Patients (NCT06893783) | Inkeun Park | 2025-09-02 |
Track Inkeun Park automatically
Every clearance here is in the API, with alerts when new ones post.